Human Hepatitis B Immunoglobulin for Intravenous Injection(PH4)

Therapeutic indications 1) Prevention of hepatitis B after liver transplantation in patients who carry the surface antigen of the hepatitis B virus. 2) Groups infected accidentally: blood transfusion, haemophile, renal dialysis patient, medical care personnel or personnel with injured skin, personnel contacting patients contaminated by blood and secretion of positive surface antigen of the hepatitis B virus, etc